TCI Wealth Advisors, Inc. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$5,000
+66.7%
1,690
+140.7%
0.00%
Q3 2021$3,000
+50.0%
702
+28.6%
0.00%
Q2 2021$2,0000.0%546
+13.0%
0.00%
-100.0%
Q1 2021$2,0004830.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders